The largest database of trusted experimental protocols

Hla dr percp

Manufactured by Miltenyi Biotec

The HLA-DR-PerCP is a fluorescent-labeled antibody reagent used for the identification and analysis of HLA-DR-positive cells in flow cytometry applications. It binds to the HLA-DR antigen expressed on the surface of various cell types, including antigen-presenting cells. The PerCP fluorochrome allows for the detection and enumeration of HLA-DR-expressing cells within a sample.

Automatically generated - may contain errors

3 protocols using hla dr percp

1

Multi-Marker Cytometry Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cytofluorimetric analysis, cells were stained with surface antibodies in PBS 5% FCS for 20 min at 4 °C. The following antibodies were used: CD133-APC, EpCAM -VioBlue, CD105-PE, CD90-VioBlue, IFNγ-PE, CD107a-APC, CCR7-FITC, CD163-PerCP-Vio700, CD206-VioBlue, HLA-DR-PerCP, CD80-APC (MIltenyi Biotec); CD56-PC7, NKp30-PE (Beckman Coulter); CD29-PE (ImmunoTools); CD146-PC7, CD73-FITC, NKp46-V450 (BD Biosciences); E-cadherin-APC (Thermo Fisher Scientific); N-cadherin-PE (Abcam); DNAM1-PE (Biolegend).
+ Open protocol
+ Expand
2

Comprehensive Immune Profiling by Cytofluorimetry

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cytofluorimetric analysis, cells were stained with surface antibodies in PBS containing 5% FCS for 20 min at 4 °C. The following antibodies were used: IFNγ-PE, CD107a-APC, HLA-DR-PerCP, CD69-FITC, PD-1-APC (Miltenyi Biotec); CD56-PC7, NKp30-PE (Beckman Coulter); NKp46-V450, CD16 PerCP-Cy5,5, CD155-AF647, PD-L1 PE-CF59 (BD Biosciences); E-cadherin-APC (Thermo Fisher Scientific); N-cadherin-PE (Abcam); NKG2D-PE/Dazzle, DNAM1-PE, CD112-PerCP-Cy5,5; MICA/B PC7 (Biolegend); ULBP3 AF405, ULBP2/5/6 PE (R&D).
+ Open protocol
+ Expand
3

Quantification of Granulocytic Myeloid-Derived Suppressor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was collected using EDTA and Heparin-coated tubes and samples were shipped to the Universitätsklinik für Kinder-und Jugendmedizin, Tübingen (Germany) at room temperature and analyzed within 24 h. MDSCs were characterized as previously described (21 (link), 22 (link)). In brief, peripheral blood mononuclear cells (PBMCs) were isolated from whole blood by Ficoll density gradient centrifugation (Lymphocyte Separation Medium; Biochrom), washed with RPMI-1640 and cell viability was confirmed by trypan blue staining. The isolated PBMC, containing only low density granulocytes, were stained with specific antibodies for G-MDSC (CD66b-FITC, CD33-PE) and M-MDSC (CD14-FITC and HLADR-PerCP) (Miltenyi Biotec) and quantified by flow cytometry using a FACSCalibur (BD). G-MDSCs were phenotypically characterized as low-density fraction granulocytes CD33+CD66b+ cells (Figure 1). The percentage of G-MDSC was determined as ratio of CD33+CD66b+ cells (P2 in Figure 1) over total PBMCs containing the low density granulocyte fraction (P1 in Figure 1). Calculations were performed with BD CellQuest Pro analysis software and FlowJo V7.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!